razoxane has been researched along with triazinate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cullinan, S; Everson, L; Gerstner, J; Krook, J; Laurie, J; McCormack, G; Schutt, A; Scott, M; Shreck, R; Windschitl, H | 1 |
| Arsenau, JC; Blessing, J; Lewis, GC; Slavik, M | 1 |
| Kaplan, BH; Lanham, R; Vogl, SE | 1 |
| Bruckner, HW; Lokich, JJ; Stablein, DM | 1 |
| Cullinan, SA; Everson, LK; Krook, JE; Scott, M; Windschitl, HE | 1 |
2 trial(s) available for razoxane and triazinate
| Article | Year |
|---|---|
Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Diarrhea; Drug Evaluation; Female; Fluorouracil; Humans; Leukopenia; Male; Middle Aged; Nausea; Random Allocation; Razoxane; Rectal Neoplasms; Semustine; Stomatitis; Thrombocytopenia; Triazines; Vomiting | 1983 |
Combination chemotherapy of advanced colorectal cancer with triazinate and ICRF-159 after failure of 5-Fluorouracil.
Topics: Clinical Trials as Topic; Colonic Neoplasms; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Fluorouracil; Folic Acid Antagonists; Humans; Leukopenia; Nausea; Piperazines; Razoxane; Rectal Neoplasms; Thrombocytopenia; Triazines | 1980 |
3 other study(ies) available for razoxane and triazinate
| Article | Year |
|---|---|
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Etoposide; Female; Humans; Maytansine; Neoplasm Recurrence, Local; Pelvic Neoplasms; Piperazines; Razoxane; Research Design; Triazines | 1982 |
Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.
Topics: Adenocarcinoma; Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Humans; Male; Methotrexate; Middle Aged; Myeloproliferative Disorders; Prognosis; Random Allocation; Razoxane; Triazines | 1982 |
Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.
Topics: Colonic Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Nitrosourea Compounds; Piperazines; Razoxane; Rectal Neoplasms; Semustine; Triazines | 1982 |